MyCartis NV

Technologiepark 4, 9052 Zwijnaarde

Telephone +32 9 2411164
Fax +32 9 2411169

This company is co-exhibitor of
Flanders Investment & Trade/ Flanders Care


Hall map

MEDICA 2016 hall map (Hall 3): stand J74

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.07  Gene tests / molecular biological diagnostic
  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.07  Gene tests / molecular biological diagnostic
  •  DNA analysis

DNA analysis

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems

Immuno assay systems

  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.07  Immuno assay systems
  •  Enzyme immunoassay (EIA, ELISA, EMIT)

Enzyme immunoassay (EIA, ELISA, EMIT)

Our products

Product category: Gene tests / molecular biological diagnostic

Evalution™ - the multiplexed analysis of biomarkers made fast and simple

Accelerate your research, trust your results
Evalution™ is MyCartis’ multiplex analysis platform tailored to the development of clinical biomarkers. It has been designed to analyze a broad range of protein and nucleic- acid based biomarkers to deliver high quality data and rapid results from minimal handling steps with unprecedented ease. Evalution™ integrates into a single instrument all the functions of incubation, washing, and optical readout for seamless operation of sophisticated assay protocols. The combination of customizable encoded microparticles with microfluidic assay plates in Evalution™ enables the analysis of proteins, nucleic-acids or other biomarkers.

The platform Evalution is intended for research use only – Not for diagnostic procedure

More Less

About us

Company details

The big revolution in healthcare today is that we are finally realizing that we are all equal, but not identical, certainly not at a molecular level. MyCartis is convinced that the future of healthcare lies in personalization. Our goal is to deliver innovative solutions for fast and cost effective identification of a patient’s specific signature of biomarkers in order to make more personal health decisions and improve quality of life. On our road to validate biomarkers on a larger scale, our intention is to build a bridge between research and medical practice by developing broadly available multiplexed biomarker solutions through technology (Evalution™) and bio-assays. The ability to quantify different types of markers on a single platform will help producing more comprehensive and coherent multiplex data sets.

MyCartis wants to help you to make your biomarkers a success. ‘Collaborate to Innovate’ is our motto and therefore we are looking forward to work with you and help you commercialize your products.

More Less

Company data

Number of employees




Area of business
  • Laboratory Equipment
  • Diagnostics